Pharmosa Biopharm Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Nov '24 Nov 20, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	7,431	10,314	7,055	-	-
Market Cap Growth	-18.69%	46.19%	-	-	-
Enterprise Value	5,941	9,330	6,778	-	-
Last Close Price	57.60	88.00	62.22	-	-
PE Ratio	-	1219.72	-	-	-
PS Ratio	140.93	32.79	-	-	-
PB Ratio	3.89	9.07	9.27	-	-
P/TBV Ratio	4.41	9.07	9.27	-	-
P/OCF Ratio	-	243.13	-	-	-
EV/Sales Ratio	117.59	29.67	-	-	-
EV/EBITDA Ratio	-	3121.44	-	-	-
Debt / Equity Ratio	0.06	0.13	0.03	0.07	0.31
Debt / EBITDA Ratio	-	7.04	-	-	-
Asset Turnover	0.03	0.29	-	-	-
Quick Ratio	24.55	12.58	24.23	13.96	4.18
Current Ratio	25.20	13.02	24.65	14.39	4.31
Return on Equity (ROE)	-18.71%	0.89%	-41.24%	-54.73%	-
Return on Assets (ROA)	-11.52%	-0.17%	-24.49%	-28.67%	-
Return on Capital (ROIC)	-11.85%	-0.17%	-25.13%	-29.48%	-
Earnings Yield	-4.12%	0.08%	-3.78%	-	-
FCF Yield	-6.12%	-0.38%	-3.81%	-	-
Buyback Yield / Dilution	-13.14%	-15.09%	-16.02%	-78.34%	-
Total Shareholder Return	-13.14%	-15.09%	-16.02%	-78.34%	-

Source: S&P Capital IQ. Standard template. Financial Sources.